Grifols, which specializes in the production of plasma derivatives, achieved a profit of $317.2 million (€266.8 million) in the first half of 2021, which translates into...
Spanish investment funds and venture capital managers have avoided the impact of the pandemic and have continued to invest in the health sector. Spanish biotech companies...